WHO fears global cancer rates could rise by 60 percent

It is estimated that global cancer rates could rise by 60 percent over the next 20 years unless cancer care is enhanced in low and middle-income countries, the World Health Organization (WHO) has warned.

3d illustration of a cancer cell and lymphocytes

Less than 15 percent of these nations offer comprehensive cancer treatment services through their public health systems, compared with more than 90 percent among their richer counterparts, according to the UN agency.

“At least 7 million lives could be saved over the next decade, by identifying the most appropriate science for each country situation, by basing strong cancer responses on universal health coverage, and by mobilizing different stakeholders to work together”, said WHO Director-General Tedros Adhanom Ghebreyesus.

As the world marks cancer day, the WHO and its specialized International Agency for Research on Cancer (IARC) have released two reports. One is aimed at setting the global agenda on the disease while the other focused on research and prevention.

Cancer should not be a ‘death sentence’

The reports highlight numerous proven interventions such as controlling tobacco use, which is responsible for a quarter of all cancer deaths, vaccinating against hepatitis B to prevent liver cancer and eliminating cervical cancer by vaccinating against HPV.

“This is a wake-up call to all of us to tackle the unacceptable inequalities between cancer services in rich and poor countries,” said WHO’s Dr. Ren Minghui, Assistant Director-General, overseeing Universal Health Coverage policy as well as communicable and noncommunicable diseases.

“If people have access to primary care and referral systems then cancer can be detected early, treated effectively and cured. Cancer should not be a death sentence for anyone, anywhere.”

Better treatment saves lives

A research assistant (left) receives training from a biologist at the National Cancer Institute of Columbia./WHO

While the reports show that progress can be achieved, the challenge will be for countries to select cancer treatments taking into consideration cost, feasibility and effectiveness.

Dr. Elisabete Weiderpass, the IARC Director, observed that there have been “tremendous advances” in cancer research over the past five decades, leading to a reduction in deaths.

She said: “High-income countries have adopted prevention, early diagnosis and screening programmes, which together with better treatment, have contributed to an estimated 20 per cent reduction in the probability of premature mortality between 2000 and 2015, but low-income countries only saw a reduction of five per cent. We need to see everyone benefitting equally.”